Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2005 6
2007 1
2008 2
2009 2
2010 2
2011 3
2012 4
2013 3
2014 6
2015 5
2016 4
2017 5
2018 2
2019 7
2020 4
2021 6
2022 12
2023 11
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Hemolytic Uremic Syndrome.
Cody EM, Dixon BP. Cody EM, et al. Among authors: dixon bp. Pediatr Clin North Am. 2019 Feb;66(1):235-246. doi: 10.1016/j.pcl.2018.09.011. Pediatr Clin North Am. 2019. PMID: 30454746 Review.
Editorial: Autoantibodies in Kidney Diseases.
Marchbank KJ, Frazer-Abel A, Dragon-Durey MA, Dixon BP. Marchbank KJ, et al. Among authors: dixon bp. Front Immunol. 2020 Sep 16;11:591338. doi: 10.3389/fimmu.2020.591338. eCollection 2020. Front Immunol. 2020. PMID: 33042166 Free PMC article. No abstract available.
Atypical Hemolytic Uremic Syndrome.
Dixon BP, Gruppo RA. Dixon BP, et al. Pediatr Clin North Am. 2018 Jun;65(3):509-525. doi: 10.1016/j.pcl.2018.02.003. Pediatr Clin North Am. 2018. PMID: 29803280 Review.
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Among authors: dixon bp. Kidney Int. 2021 Jul;100(1):225-237. doi: 10.1016/j.kint.2020.10.046. Epub 2020 Dec 8. Kidney Int. 2021. PMID: 33307104 Free article. Clinical Trial.
Clinical course and management of children with IgA vasculitis with nephritis.
Stone HK, Mitsnefes M, Dickinson K, Burrows EK, Razzaghi H, Luna IY, Gluck CA, Dixon BP, Dharnidharka VR, Smoyer WE, Somers MJ, Flynn JT, Furth SL, Bailey C, Forrest CB, Denburg M, Nehus E. Stone HK, et al. Among authors: dixon bp. Pediatr Nephrol. 2023 Nov;38(11):3721-3733. doi: 10.1007/s00467-023-06023-8. Epub 2023 Jun 14. Pediatr Nephrol. 2023. PMID: 37316676 Free PMC article.
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies.
Nester C, Appel GB, Bomback AS, Bouman KP, Cook HT, Daina E, Dixon BP, Rice K, Najafian N, Hui J, Podos SD, Langman CB, Lightstone L, Parikh SV, Pickering MC, Sperati CJ, Trachtman H, Tumlin J, de Vries AP, Wetzels JFM, Remuzzi G. Nester C, et al. Among authors: dixon bp. Am J Nephrol. 2022;53(10):687-700. doi: 10.1159/000527167. Epub 2022 Nov 24. Am J Nephrol. 2022. PMID: 36423588 Free article. Clinical Trial.
The complement system in pediatric acute kidney injury.
Stenson EK, Kendrick J, Dixon B, Thurman JM. Stenson EK, et al. Among authors: dixon b. Pediatr Nephrol. 2023 May;38(5):1411-1425. doi: 10.1007/s00467-022-05755-3. Epub 2022 Oct 6. Pediatr Nephrol. 2023. PMID: 36203104 Free PMC article. Review.
Tuberous sclerosis complex renal disease.
Dixon BP, Hulbert JC, Bissler JJ. Dixon BP, et al. Nephron Exp Nephrol. 2011;118(1):e15-20. doi: 10.1159/000320891. Epub 2010 Nov 11. Nephron Exp Nephrol. 2011. PMID: 21071977 Free PMC article. Review.
Management of Hematuria in Children.
Bignall ONR 2nd, Dixon BP. Bignall ONR 2nd, et al. Among authors: dixon bp. Curr Treat Options Pediatr. 2018 Sep;4(3):333-349. doi: 10.1007/s40746-018-0134-z. Epub 2018 Jun 14. Curr Treat Options Pediatr. 2018. PMID: 30128264 Free PMC article.
75 results